India moves to bolster global trust in medicines with real-time tracking

India is taking significant steps to enhance global confidence in its pharmaceutical sector by implementing a state-of-the-art digital tracking system for its drug regulatory framework. This initiative involves replacing traditional manual ledgers with a QR-code-based tracking mechanism, aimed at ensuring transparency and traceability in the drug supply chain. Additionally, the government has mandated videography during sample testing processes to further curb corruption and malpractice. These measures are expected to not only streamline operations within the pharmaceutical industry but also reassure both domestic and international stakeholders about the integrity and safety of Indian medicines. As a major player in the global pharmaceutical market, India’s efforts to modernize its regulatory practices are aligned with international standards, reinforcing its commitment to providing high-quality healthcare solutions. This move also reflects India’s broader strategy to bolster its reputation in the global market, especially in light of increasing scrutiny over drug safety and efficacy. Overall, the digitization of the drug regulatory framework marks a pivotal moment for India's pharmaceutical landscape, fostering an environment of accountability and trust.